A

Abingworth Portfolio holdings

AUM $307M
This Quarter Return
+40.85%
1 Year Return
+93.6%
3 Year Return
+207.29%
5 Year Return
+452.78%
10 Year Return
AUM
$468M
AUM Growth
+$468M
Cap. Flow
-$16.7M
Cap. Flow %
-3.57%
Top 10 Hldgs %
97.64%
Holding
17
New
1
Increased
1
Reduced
3
Closed

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PCVX icon
1
Vaxcyte
PCVX
$4B
$206M 44.03% 4,168,718
PSNL icon
2
Personalis
PSNL
$434M
$96.7M 20.68% 4,462,452 -986,842 -18% -$21.4M
PHAT icon
3
Phathom Pharmaceuticals
PHAT
$864M
$44.5M 9.52% 1,203,135
SLNO icon
4
Soleno Therapeutics
SLNO
$3.6B
$25.8M 5.51% 10,302,602
CRSP icon
5
CRISPR Therapeutics
CRSP
$4.71B
$21.7M 4.64% 259,599 -259,599 -50% -$21.7M
NCNA
6
NuCana
NCNA
$6.09M
$17.2M 3.69% +3,333,333 New +$17.2M
VRNA
7
Verona Pharma
VRNA
$9.16B
$15.3M 3.28% 2,457,499 +1,555,556 +172% +$9.71M
XCUR icon
8
Exicure
XCUR
$35.4M
$12.1M 2.58% 6,977,000
SRRA
9
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$9.21M 1.97% 876,541
SIEN
10
DELISTED
Sientra, Inc.
SIEN
$8.13M 1.74% 2,390,843
PRTK
11
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$5.62M 1.2% 1,041,131
MTEM
12
DELISTED
Molecular Templates, Inc.
MTEM
$2.18M 0.47% 200,000
SYRE icon
13
Spyre Therapeutics
SYRE
$996M
$1.7M 0.36% 240,500
CBAY
14
DELISTED
Cymabay Therapeutics
CBAY
$947K 0.2% 131,036
TARA icon
15
Protara Therapeutics
TARA
$120M
$344K 0.07% 20,610 -33,002 -62% -$551K
OBSV
16
DELISTED
ObsEva SA Ordinary Shares
OBSV
$218K 0.05% 87,999
OCGN icon
17
Ocugen
OCGN
$319M
$2K ﹤0.01% 7,111